Google
Trusted Resources: News & Events
Latest announcements and gatherings
Exemplar Genetics Awarded Subcontract to Advance New Therapeutic Models for Sickle Cell Disease
Exemplar Genetics, a wholly owned subsidiary of Intrexon Corporation (NYSE: XON) committed to enabling the study of life-threatening human diseases, has been awarded a subcontract to create genetically engineered miniswine models of sickle cell disease as part of a national resource that could lead to new treatments for the disorder.
+myBinderRelated Content
-
BCL11A-based gene therapy for sickle cell disease passes key preclinical testA precision-engineered gene therapy viru...
-
Kwaku Ohene-Frempong, MD (Remembering)We are devastated to learn of the death ...
-
Nancy Green, MDNancy Green, MD is a pediatric hematolog...
-
Hydroxyurea Treatment for Sickle Cell DiseaseHydroxyurea is a medicine that can help ...
-
Environmental determinants of severity in sickle cell diseaseSickle cell disease causes acute and chr...
-
10th James Faucett Virtual/Pop-Up Sickle Cell WalkWe are in this fight together for Sickle...
-
Today’s Faces of Sickle Cell Disease: Linda Thomas WadeLinda Thomas is a health care educator, ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
SomeBodyToTalkTo connects people affected by rare diseases with trusted resources, supportive communities, and opportunities to share their experiences.